Original document(13 pages) Authorized document(11 pages) 中文版
    The quality control method for ginseng and aconite preparation includes identifying aconite alkaloid and/or determining the content of gensenoside and aconite alkaloid. In the quality control, the determination of aconite alkaloid content is to compare the spot size directly with standard product as reference. The method of determining ginseng and aconite content is simple and intuitive and can result in stable quality and scientific detection.
Application Number
申请号		 02149369 Application Date
申请日		 2002.11.13
Title 名称 Quality controlling method for Shenfu injection preparation
Publication Number
公开号		 1501079 Publication Date
公开日		 2004.06.02
Approval Pub. Date Granted Pub. Date 2006.02.15
International Classification 分类号 G01N33/15
Applicant(s) Name
申请人		 Ya'an Sanjiu Pharmaceutical Co., Ltd.
Address 地址 625000
Inventor(s) Name 发明人
Attorney & Agent 代理人 zhang tao

  
Fat regulating tablet for treating hyperlipidemia and preparing method thereof
Florescence controlling method for rice hybrid production
Preparation method of isotonic houttuynia injection
Preparation of isotomic Shengmei injecta
Ginseng-monkshood skeleton slow-release hydrophilic gel skeleton tablet for treating qi asthenia and yang depletion and preparing method thereof
Ginseng-monkshood skeleton slow-release preparation wax skeleton tablet for treating qi athenia and yang depletion and preparing method thereof
Ginseng-monkshood skeleton slow-release endo gastric detention tablet for treating qi asthenia and yang depletion and preparing method thereof
Gineng-monkshood skeleton slow-releae insoluble skeleton tablet for treating qi asthenia and yang depletion and preparing method thereof
Ginseng and aconite capsule for treating qi vacuity and yang desertion and its preparation method
Method of producing coronatine by burkholderiacepacia and fermentation culture medium thereof
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.